SAN DIEGO, June 15, 2016 /PRNewswire/ -- Evofem, a biotechnology company focused on the development and commercialization of women's health products, announced today that CEO, Saundra Pelletier, has been selected to present at the upcoming Cavendish Global Health Impact Forum co-hosted with Biocom, June 20-23, 2016, in San Diego.
The Cavendish Global community consists of more than 200 preeminent foundations and family offices from around the world with combined assets of over $225 billion. The Cavendish Impact Forums are hosted by leading institutions around the world and take place three times each year to assist family offices and foundations with developing and implementing their individual pro-social impact investing, grant-giving and philanthropy programs within health and the life sciences.
The theme of the upcoming 2016 San Diego Forum is Innovation, Philanthropy and Investing Inspired for Impact. The Forum will showcase presentations and panel discussions by leading foundations, research institutions and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment.
As one of the companies selected to participate and present at the upcoming Forum in San Diego, Saundra Pelletier, CEO of Evofem and WomanCare Global will present the unique innovations being developed by Evofem and WomanCare Global to meet the contraceptive needs of women across the globe. "Our team is working diligently to develop innovative treatments to meet the unmet reproductive health care needs of women," said Saundra Pelletier. "There are approximately 225 million women who have a need for modern contraception globally. We look forward to meeting with accomplished entrepreneurs, thought-leaders and philanthropists who echo our mission addressing unintended pregnancy and gender inequality around the world."
Evofem Holdings, Inc. seeks to address a growing global contraceptive market, while delivering effective, woman-controlled products with global distribution. Evofem has two lead product candidates: Amphora®, a vaginal contraceptive gel, and the Nestorone® Ring, a one-year contraceptive vaginal ring, both of which have completed Phase III clinical studies. For more information on the Company, visit www.evofem.com.
About WomanCare Global
WomanCare Global (WCG) is a global nonprofit committed to meeting the vast unmet demand for family planning by providing access to reproductive health solutions for women and girls around the world. WCG's core mission is strongly aligned with the "If You Don't Tell Them, Then Who Will?" campaign by educating and empowering women when it comes to reproductive health and their bodies, particularly in making sure that they are getting their information from a reliable source. Encouraging women to understand what choices are available and how those choices impact their lives and the lives of their families is core to the organization. More information can be found at www.womancareglobal.org
About Cavendish Global
Cavendish Global provides family offices and their foundations with a discrete, peer-to-peer knowledge expansion and relationship-building environment, combined with the innovative resources required to help develop and implement their individual pro-social impact investment and philanthropy programs within health and the life sciences. Cavendish Global provides family offices with a number of innovative resources, which includes Cavendish Impact Forums. A unique gathering of leading family offices, Cavendish Impact Forums take place three times each year. For more information: http://cavendishglobal.com
(858) 550-1900, ext. 241
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/evofem-ceo-saundra-pelletier-to-address-the-cavendish-global-health-impact-forum-at-biocom-on-innovations-in-reproductive-health-care-around-the-globe-300284789.html